Balsalazide
Generic name: Balsalazide
Dosage form: oral capsule (750 mg)
Drug class:
5-aminosalicylates
Usage of Balsalazide
The Colazal brand of balsalazide is used to treat mild to moderate active ulcerative colitis in adults and children who are at least 5 years old.
The Giazo brand of balsalazide is used to treat mild to moderate active ulcerative colitis in men who are at least 18 years old.
Balsalazide may also be used for purposes not listed in this medication guide.
Balsalazide side effects
Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Balsalazide may cause serious side effects. Call your doctor at once if you have:
Common side effects of balsalazide may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Balsalazide
You should not use balsalazide if you are allergic to balsalazide or mesalamine, or to aspirin or other salicylates (including Kaopectate, Pamprin, Pepto-Bismol, Tricosal, Trilisate, and others).
Tell your doctor if you have ever had:
Balsalazide tablets contain sodium. Talk to your doctor before using this form of balsalazide if you are on a low salt diet.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known whether balsalazide will harm an unborn baby. However, having active ulcerative colitis during pregnancy may cause premature delivery or low birth weight. The benefit of treating ulcerative colitis may outweigh any risks to the baby.
If you are breastfeeding, tell your doctor if you notice diarrhea in the nursing baby.
Balsalazide capsules should not be given to a child younger than 5 years old. Balsalazide tablets should not be given to anyone under 18 years old.
Relate drugs
- Apriso
- Asacol HD
- Colazal
- Balsalazide
- Canasa
- Canasa Pac rectal
- Delzicol
- Dipentum
- Giazo
- Lialda
- Mesalamine
- Mesalamine (Oral)
- Mesalamine rectal
- Olsalazine
- Pentasa
- Rowasa
- SfRowasa
- SfRowasa rectal
How to use Balsalazide
Usual Adult Dose for Ulcerative Colitis -- Active:
Oral capsules:Usual dose: Three 750 mg capsules orally 3 times a day for up to 8 weeks-Some patients in the clinical trials required up to 12 weeks of treatment.-Safety and efficacy beyond 12 weeks have not been established.GIAZO(R) tablets; male patients:Three 1.1 gram tablets orally twice a day, with or without food, for up to 8 weeks-Effectiveness in female patients was not demonstrated in clinical trials.-Safety and efficacy beyond 8 weeks have not been established.Use(s): Treatment of mildly to moderately active ulcerative colitis.
Usual Pediatric Dose for Ulcerative Colitis -- Active:
5 years and older, oral capsules:Three 750 mg capsules orally 3 times a day for up to 8 weeksOROne 750 mg capsule orally 3 times a day for up to 8 weeksComments:-Safety and efficacy beyond 8 weeks have not been establishedUse(s): Treatment of mildly to moderately active ulcerative colitis.
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
What other drugs will affect Balsalazide
Other drugs may affect balsalazide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions